Quinidine sulfate

CAS No. 6591-63-5

Quinidine sulfate( Quinidine sulfate dihydrate | Chinidin Sodium | Pitayine Sodium | β-quinine Sodium )

Catalog No. M21195 CAS No. 6591-63-5

Quinidine sulfate dihydrate is a potent and selective cytochrome P450db inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 56 In Stock
5MG 35 In Stock
10MG 48 In Stock
25MG 67 In Stock
50MG 94 In Stock
100MG 142 In Stock
200MG 214 In Stock
500MG 359 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Quinidine sulfate
  • Note
    Research use only, not for human use.
  • Brief Description
    Quinidine sulfate dihydrate is a potent and selective cytochrome P450db inhibitor.
  • Description
    Quinidine sulfate dihydrate is a potent and selective cytochrome P450db inhibitor.(In Vitro):Quinidine hydrochloride monohydrate blocks WT mSlo3 (KCa5.1) channels with an IC50 of 19.9±1.41 μM and Hill slope of 1.15±0.15 (n=7). Again, the potency of inhibition by Quinidine hydrochloride monohydrate is higher for F304Y mSlo3 (IC50 of 2.42±0.60 μM, n=9, P<0.005; Hill slope of 0.98±0.12), but lower with R196Q mSlo3 (IC50 of 38.4±6.77 μM, n=5, P<0.001; Hill slope of 1.05±0.16). The inhibition of F304Y mSlo3 by Quinidine hydrochloride monohydrate is observed to have some time dependence.(In Vivo):Direct application of Quinidine hydrochloride monohydrate on the sciatic nerve produces a dose-related decrease in amplitude at ascending somato-sensory evoked potential (SSEP) and descending compound muscle action potentials (CMAP) when comparing baseline with other time points, or when comparing the experimental left limb to the right contra-lateral glucose-treated limb. The latencies of SSEPs and CMAP potentials after Quinidine hydrochloride monohydrate applications are increased compare to baseline and the contralateral side.
  • In Vitro
    Quinidine sulfate dihydrate shows cytotoxicity against MES-SA cells, and induces apoptosis.
  • In Vivo
    Quinidine sulfate dihydrate shows effects on the PTZ-induced seizure threshold. Animal Model:Male mice of the NMRI strain (age 5-6 weeks and weight 25-30 g)Dosage:10, 20, and 30 mg/kg Administration: Intraperitoneal injection; 10, 20, and 30 mg/kg; once Result:Increased the threshold dose for the onset to tonic hind limb extension at a dose of 30 mg/kg, compared to the saline-treated control group (p<0.05).
  • Synonyms
    Quinidine sulfate dihydrate | Chinidin Sodium | Pitayine Sodium | β-quinine Sodium
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    P450
  • Recptor
    CYP450
  • Research Area
    Cardiovascular Disease
  • Indication
    Arrhythmia

Chemical Information

  • CAS Number
    6591-63-5
  • Formula Weight
    782.9
  • Molecular Formula
    C40H54N4O10S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:100 mg/mL (154.12 mM)Ethanol:100 mg/mL (154.12 mM)H2O:9 mg/mL (13.87 mM)
  • SMILES
    C=CC1CN2CCC1CC2C(O)c1ccnc2ccc(OC)cc12.C=CC1CN2CCC1CC2C(O)c1ccnc2ccc(OC)cc12.O.O.O=S(=O)(O)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Tsuruo T Iida H Kitatani Y et al. Effects of Quinidine and Related Compounds on Cytotoxicity and Cellular Accumulation of Vincristine and Adriamycin in Drugresistant Tumor Cells[J]. Cancer Research 1984 44(10):4303-4307.
molnova catalog
related products
  • CYP1B1-IN-5

    CYP1B1-IN-5 is a selective and potent cytochrome P450 1B1 (CYP1B1) inhibitor with an IC50 of 4.7 nM.CYP1B1-IN-5 can be used for the study of metabolism-related diseases.

  • Apigenin

    Apigenin is a potent P450 inhibitor for CYP2C9 with Ki of 2 μM.

  • Enerisant HCl

    Enerisant HCl is a novel potent and selective histamine H3 receptor antagonist, a substrate for P-gp, mediated by cytochrome P450 (CYP) and transporter proteins.